Startups seek to create robotic chemists; Psi expands in North America;

> For years, drug developers have been outsourcing R&D tasks to other groups of people, but a new class of startups is working to automate much of the process and, effectively, create robotic chemists. News

> Swiss CRO Psi is expanding its North American operation. More

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.